SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001427570-18-000097
Filing Date
2018-12-27
Accepted
2018-12-27 16:57:41
Documents
7
Period of Report
2018-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K obalon-2018atmelcx8xk.htm 8-K 57079
2 EXHIBIT 1.1 ex11-equitydistributionagr.htm EX-1.1 277693
3 EXHIBIT 5.1 ex51opinion-atmdecember2018.htm EX-5.1 13056
4 EXHIBIT 10.1 ex101-purchaseagreementlpc.htm EX-10.1 332373
5 EXHIBIT 10.2 ex102-registrationrightsag.htm EX-10.2 104276
6 ex51opinionatmdecembe_image1.gif GRAPHIC 13565
7 lathamheaderv2.jpg GRAPHIC 25675
  Complete submission text file 0001427570-18-000097.txt   834613
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 181255156
SIC: 3841 Surgical & Medical Instruments & Apparatus